UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease
by Lee Han-soo
2019-11-27 18:21
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics
by Lee Han-soo
2019-11-26 18:48
Amgen releases analysis result showing benefits of LDL-C treatment
by Lee Han-soo
2019-11-26 17:05
Roche’s flu treatment Xofluza wins approval
by Kim Yun-mi
2019-11-26 16:08
Immunotherapies give hope for esophageal cancer patients
by Kim Yun-mi
2019-11-26 15:37
라인
GC Labcell hands over NK cell-treating tech to US lab
by Lee Han-soo
2019-11-26 15:33
SK Biopharm to speed up global advance through XCOPRI’s launch
by Lee Han-soo
2019-11-26 14:16
Huons Global wins KGMP certification for BTX plant
by Lee Han-soo
2019-11-25 16:00
Gtree enrolls 200 patients for US trial of dry eye treatment
by Lee Han-soo
2019-11-25 14:49
Daewoong renews EU GMP certification for BTX plant
by Lee Han-soo
2019-11-25 11:55
라인
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently
by Lee Han-soo
2019-11-22 17:03
Bridge Biotherapeutics aims to become global NRDO company
by Lee Han-soo
2019-11-22 15:10
‘SGLT-2 inhibitor may prevent retinopathy in type-2 diabetes’
by Lee Han-soo
2019-11-21 15:21
‘Sprycel showed longer efficacy than nilotinib for chronic myeloid leukemia’
by Lee Han-soo
2019-11-21 14:26
CJ HealthCare to export gastric acid blocker to Thailand
by Lee Han-soo
2019-11-21 10:54
라인
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’
by Kim Yun-mi
2019-11-20 16:16
Remed aims to expand global presence through IPO
by Lee Han-soo
2019-11-20 15:30
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab
by Jeong Sae-im
2019-11-19 17:18
‘Udenafil improved exercise in single ventricle heart disease’
by Jeong Sae-im
2019-11-18 14:48
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
by Kim Yun-mi
2019-11-15 17:48
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top